These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuroprotection targets after traumatic brain injury. Wang KK; Larner SF; Robinson G; Hayes RL Curr Opin Neurol; 2006 Dec; 19(6):514-9. PubMed ID: 17102687 [TBL] [Abstract][Full Text] [Related]
3. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Ikonomidou C; Turski L Lancet Neurol; 2002 Oct; 1(6):383-6. PubMed ID: 12849400 [TBL] [Abstract][Full Text] [Related]
4. Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury. Yi JH; Hazell AS Neurochem Int; 2006 Apr; 48(5):394-403. PubMed ID: 16473439 [TBL] [Abstract][Full Text] [Related]
5. Medical treatment and neuroprotection in traumatic brain injury. Clausen T; Bullock R Curr Pharm Des; 2001 Oct; 7(15):1517-32. PubMed ID: 11562296 [TBL] [Abstract][Full Text] [Related]
6. Stretch-induced injury in organotypic hippocampal slice cultures reproduces in vivo post-traumatic neurodegeneration: role of glutamate receptors and voltage-dependent calcium channels. Cater HL; Gitterman D; Davis SM; Benham CD; Morrison B; Sundstrom LE J Neurochem; 2007 Apr; 101(2):434-47. PubMed ID: 17250683 [TBL] [Abstract][Full Text] [Related]
7. Cannabinoids as neuroprotective agents in traumatic brain injury. Biegon A Curr Pharm Des; 2004; 10(18):2177-83. PubMed ID: 15281893 [TBL] [Abstract][Full Text] [Related]
8. Central nervous system resuscitation. McIntosh TK; Garde E; Saatman KE; Smith DH Emerg Med Clin North Am; 1997 Aug; 15(3):527-50. PubMed ID: 9255131 [TBL] [Abstract][Full Text] [Related]
10. The role of excitatory amino acids in severe brain trauma: opportunities for therapy: a review. Zauner A; Bullock R J Neurotrauma; 1995 Aug; 12(4):547-54. PubMed ID: 8683605 [TBL] [Abstract][Full Text] [Related]
13. Neurological deterioration as a potential alternative endpoint in human clinical trials of experimental pharmacological agents for treatment of severe traumatic brain injuries. Executive Committee of the International Selfotel Trial. Morris GF; Juul N; Marshall SB; Benedict B; Marshall LF Neurosurgery; 1998 Dec; 43(6):1369-72; discussion 1372-4. PubMed ID: 9848851 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment of traumatic brain injury: a review of agents in development. Hatton J CNS Drugs; 2001; 15(7):553-81. PubMed ID: 11510625 [TBL] [Abstract][Full Text] [Related]
15. Pharmacology of traumatic brain injury: where is the "golden bullet"? Beauchamp K; Mutlak H; Smith WR; Shohami E; Stahel PF Mol Med; 2008; 14(11-12):731-40. PubMed ID: 18769636 [TBL] [Abstract][Full Text] [Related]
16. Cooling the injured brain: how does moderate hypothermia influence the pathophysiology of traumatic brain injury. Sahuquillo J; Vilalta A Curr Pharm Des; 2007; 13(22):2310-22. PubMed ID: 17692002 [TBL] [Abstract][Full Text] [Related]
17. [Neurochemical changes and current pharmacological approaches in craniocerebral trauma]. Kossmann T; Lenzlinger PM; Stover JF; Stocker R; Morganti-Kossmann MC; Trentz O Unfallchirurg; 1997 Aug; 100(8):613-22. PubMed ID: 9381209 [TBL] [Abstract][Full Text] [Related]
18. Novel pharmacologic strategies in the treatment of experimental traumatic brain injury: 1998. McIntosh TK; Juhler M; Wieloch T J Neurotrauma; 1998 Oct; 15(10):731-69. PubMed ID: 9814632 [TBL] [Abstract][Full Text] [Related]
19. Traumatic brain injury: can the consequences be stopped? Park E; Bell JD; Baker AJ CMAJ; 2008 Apr; 178(9):1163-70. PubMed ID: 18427091 [TBL] [Abstract][Full Text] [Related]